Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if intraocular infusion of low-molecular weight
heparin (enoxaparin) influences postoperative inflammation following pediatric cataract
surgery with intraocular lens (IOL) implantation.